Medscape5d
Paxlovid: Worth a Long Look for Easing Long COVID
New research showed some long COVID patients get symptom relief by taking an extended course of Paxlovid. Data are ...
HUB2d
Convalescent plasma offers a 'blueprint' for future pandemics
Hopkins researchers help secure full FDA approval to treat immunocompromised COVID-19 patients—paving the way to explore ...
CNN5d
Feeling sick? Here’s what to take and what to avoid, according to a doctor
There are two instances where people should consider testing. The first is if they would qualify for antiviral treatment for Covid-19 or influenza. These are individuals at high risk for ...
I See The Bull Case For Invivyd, But I'm Not Married To It
Invivyd, Inc. is a microcap biotech company focusing on antibody-based treatments for infectious diseases like COVID-19.
Long-COVID patients are frustrated that federal research hasn’t found new treatments
Along with claiming the lives of 1.2 million Americans, the COVID-19 pandemic has been described as a mass disabling event.
Doctors say antivirals are underutilized in fighting flu and COVID-19
Some in the medical community say that antiviral treatments are underutilized and could help more people recover from ...
Nanoparticles damage coronavirus in unexpected way, paving way for new disinfection technology
A new way to neutralize coronavirus and other membrane-surrounded viruses has been discovered by researchers from the Swedish ...
AI models forecast COVID-19 risks and treatment for hospitalized patients
Seasonal influenza, respiratory syncytial virus (RSV), and COVID-19 are actively circulating throughout the United States.